Futura Medical plc
FAMDF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.59 | -1.99 | -2.31 | -0.25 |
| FCF Yield | -1.46% | -1.13% | -4.42% | -4.04% |
| EV / EBITDA | 62.34 | -11.01 | -20.93 | -16.38 |
| Quality | ||||
| ROIC | 12.76% | -120.16% | -123.88% | -50.98% |
| Gross Margin | 69.58% | 57.22% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.30 | -0.08 | 0.84 | 0.66 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -42.74% | 85.64% | -51.78% | 5.68% |
| Safety | ||||
| Net Debt / EBITDA | -4.83 | 1.13 | 0.59 | 1.77 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 9.29 | 3,913.70 | 0.00 | 0.00 |
| Cash Conversion Cycle | -56.08 | -141.59 | -4,665.89 | -18,084.01 |